BioSpace News Archive

Business

Cobra Biologics and the University of Leeds Collaborate in BioProNET Funded Project

£100K grant will fund proof-of-concept studies to optimise bioprocessing of gene therapy vectors using hydrodynamic fluid flow fields

November 13, 2018
·
6 min read
Genetown

With $65 Million in Hand, Kymera Will Put Its Protein Degradation Technology to the Test

Kymera Therapeutics secured $65 million in a Series B funding round that was supported, in part, by the investment arms of Pfizer and Sanofi.

November 13, 2018
·
2 min read
·
Alex Keown
Drug Development

VistaGen Therapeutics Receives Notices of Allowance in Australia and Japan for AV-101 Patents Covering Treatment of Depression

VistaGen’s oral NMDA receptor glycine B antagonist in Phase 2 development for adjunctive treatment of major depressive disorder.

November 13, 2018
·
1 min read
Business

Bacteria, Viruses and Fungi Are Everywhere -- You Should Be Happy About This

Rob Dunn, a professor of applied ecology at North Carolina State University in Raleigh recently wrote a book, Never Home Alone. In this book, he describes how millions of microorganisms, bacteria, fungi, viruses, parasites and insects live in your home—and in and on your body.

November 13, 2018
·
4 min read
·
Mark Terry
Business

Fujitsu Develops Technology to Predict Biochemical Reactions, Clarifying the Mechanisms of Genetic Disorders

Advancing new drug discovery and precision medicine with the ability to predict large volumes of unknown chemical reactions

November 13, 2018
·
8 min read
Bio NC

Ribometrix Launches With $30 Million to Develop RNA Structure-Based Drugs

Ribometrix closed on a Series A financing worth $30 million. The round was led by M Ventures, with participation of new investors Amgen Ventures, Pappas Capital and Illumina Ventures.

November 13, 2018
·
3 min read
·
Mark Terry
Novel Technique Can Potentially Improve Success of Ovarian Cancer Treatment, Study Reveals

Instead of destroying a tumour’s blood supply, a first-ever University of Guelph study has proven that opening up the vessels is potentially more effective when it comes to fighting ovarian cancer.

November 13, 2018
·
2 min read
Business

Roivant Sciences Raises $200 Million, Bringing Its Valuation to $7 Billion

Vivek Ramaswamy’s Roivant Sciences, the umbrella company to 14 Vant companies, including Datavant, Enzyvant Sciences, Urovant Sciences and others, raised another $200 million in equity financing.

November 13, 2018
·
3 min read
·
Mark Terry
Business

Dr. Kevin Moses Named Vice President of Science Programs at The Kavli Foundation

A former leader at the Wellcome Trust, HHMI/Janelia and CZI to manage the Foundation’s portfolio of science programs.

November 13, 2018
·
3 min read
Biotech Beach

Regen BioPharma, Inc. Reports Additional New NR2F6 Small Molecule Inhibitors

Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) researchers have identified three new series of small molecule drugs that inhibit NR2F6, bringing the total number of these series to five.

November 13, 2018
·
2 min read